Results 231 to 240 of about 36,199 (325)

Pharmacoepidemiology of Lateral Amiotrophic Sclerosis in the Republic of Belarus [PDF]

, 2017
Т. И. Бондаренко
openalex   +1 more source

Can large language models detect drug-drug interactions leading to adverse drug reactions? [PDF]

Ther Adv Drug Saf
Sicard J, Montastruc F, Achalme C, Jonville-Bera AP, Songue P, Babin M, Soeiro T, Schiro P, de Canecaude C, Barus R.   +9 more
europepmc   +1 more source

A Report from Task Force on Pharmacoepidemiology and Pharmaceutical Industory

, 2009
Kenichi Matsui, Keiji Imai, Hiromi UEHARA, Akira KOKAN, Toshimichi NISHI, Hiroko Marui, Kiyoshi Kubota   +6 more
openalex   +2 more sources

Instrumental variable analysis in the context of dichotomous outcome and exposure with a numerical experiment in pharmacoepidemiology [PDF]

, 2018
Babagnidé François Koladjo, Sylvie Escolano, Pascale Tubert‐Bitter   +2 more
openalex   +1 more source

Electro-encephalographic surrogate measures fail to describe the pharmacodynamic interaction between ketamine and propofol. [PDF]

, 2004
Mortier, Eric, Struys, Michel, VEREECKE, HUGO   +2 more
core   +1 more source

Rethinking diuretic use in acute kidney injury: effective prevention or false hope? [PDF]

J Intensive Care
Yamada H, Murata M, Hashimoto H.
europepmc   +1 more source

RE: "IMMORTAL TIME BIAS IN PHARMACOEPIDEMIOLOGY"

, 2009
Victor A. Kiri, Gilbert MacKenzie
openalex   +1 more source

Strengthening standards, transparency, and collaboration to support medicine evaluation: Ten years of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) [PDF]

, 2018
Xavier Kurz, Susana Perez‐Gutthann
openalex   +1 more source

Reversible cerebral vasoconstriction syndrome in a methylphenidate-treated patient: a case report. [PDF]

BMC Neurol
Osmont MN, Malrain C, Ruellan AL, Benchikh A, Herlem E, Polard E, Scailteux LM.   +6 more
europepmc   +1 more source

Good Pharmacovigilance Planning in Japan: Proposals from the “Task Force for Good Pharmacovigilance Planning in Japan” of Japanese Society for Pharmacoepidemiology (JSPE)

, 2015
Osamu Komiyama, Kotonari AOKI, Akira KOKAN, Kiyoshi Kubota   +3 more
openalex   +2 more sources